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Imaging the Prodrug-to-Drug Transformation of a
5-Fluorouracil Derivative in Skin by Confocal Raman
Microscopy
Guojin Zhang1, David J. Moore2, Kenneth B. Sloan3, Carol R. Flach1 and Richard Mendelsohn1
The widespread adoption of transdermal drug delivery has been limited by the barrier properties of the
outermost layer of the epidermis, the stratum corneum (SC). A variety of approaches have been developed to
overcome the barrier, including the use of a prodrug form of an active therapeutic agent to enhance
transdermal delivery. Once in the epidermis, the pro-molecule is converted to the active drug by endogenous
enzymes or simple chemical hydrolysis. The prodrug selected for the current studies, 1-ethyloxycarbonyl-5-
fluorouracil, is known to enhance transdermal delivery of 5-fluorouracil, an important systemic antitumor drug.
Using confocal Raman microscopy on pigskin biopsies treated with prodrug, we are able to image the spatial
distribution of both prodrug and drug in the SC and viable epidermis, thereby providing information
about permeation and metabolism. This approach may readily be extended to a variety of dermatological
processes.
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INTRODUCTION
Transdermal delivery of drugs offers several important
advantages for therapeutics, including ease of access, control
of incorporation kinetics, and the relative non-invasiveness of
application procedures (Barry, 2004; Prausnitz et al., 2004).
Various methods based on transient physical modification of
the stratum corneum (SC) barrier have been developed to
increase delivery of active agents, for example, iontophoresis,
electroporation, and the use of chemical permeation en-
hancers. An alternative strategy, using prodrugs, entails
modification of the physical and chemical properties of the
active molecule. Evaluation of the success of transdermal
delivery is limited by the absence of techniques that monitor in
situ the spatial distribution of the drug, prodrug, or delivery
vehicle. Any such method must be able to examine the
outermost layers of intact skin in a non-perturbing manner and
to distinguish closely related chemical species in the skin.
The Raman spectrum of a molecule provides a useful
fingerprint for identification of substances without the
necessity for external labels (which may perturb the physical
properties of the molecules under study). Modern technology
permits the acquisition of Raman spectra from skin in a
microscopically resolved confocal manner (Caspers et al.,
2001), thereby providing a convenient, non-destructive method
for monitoring the spatial distribution of exogenous materials
and their biochemical transformations in intact skin.
5-Fluorouracil (5FU), an important systemic antitumor
drug (Longley et al., 2003), is also used to treat cancerous or
precancerous conditions in skin including solar keratoses,
actinic keratosis, superficial basal cell carcinoma, and
Bowen’s disease. Furthermore, 5FU is used to treat non-
cancerous conditions in which cells are dividing rapidly, for
example, psoriasis (Pearlman et al., 1986). The delivery of
5FU in conventional topical preparations has been subopti-
mal, requiring methods such as light curettage to improve
therapeutic utility (Epstein, 1985). A variety of prodrugs from
5FU have been prepared, one of which, 1-ethyloxycarbonyl-
5FU (pro-5FU), provided a 25-fold increase in transdermal
delivery (Beall et al., 1994). The molecular structures of both
prodrug and drug species are shown in the inset to Figure 1a.
In this article, we describe the application of confocal Raman
microscopy to image the spatial distribution of pro-5FU to
5FU conversion in skin.
RESULTS AND DISCUSSION
Differences in the Raman spectra (Figure 1a) of aqueous
solutions of the prodrug and drug are significant in the low
frequency region. Several bands likely arising from ring
vibrations are diagnostic for each molecule, illustrating the
potential for in situ differentiation of these molecules in the
confocal Raman experiment. Included in Figure 1a is a
spectrum of isopropyl myristate (IPM), the delivery solvent for
the pro-5FU suspension. Only a few Raman bands in the
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spectrum of IPM are observed in the same region as pro-5FU
or 5FU. Bands at 866 and 637 cm1, free from interference
from IPM bands, were chosen to monitor the relative
concentrations of prodrug and drug, respectively. Spectra
are presented over a higher wavenumber range in Figure S1a
and S1b, supporting the selection of these two discrete bands
in the low wavenumber region.
A suspension of pro-5FU was applied to intact pigskin
(221C) for 20 hours. Subsequently, Raman spectra were
acquired at increasing depths beneath the skin surface in
5 mm increments. These were compared to spectra of
untreated pigskin at equivalent depths (Figure 1b). In the
Raman spectra of treated skin, features from prodrug and drug
are observed along with Raman bands of the protein and lipid
constituents of the SC. In a control experiment, pro-5FU was
determined to be chemically stable in an IPM suspension
monitored over a 1-month period. In an additional control
experiment, when a suspension of 5FU in IPM was applied to
skin, using the current experimental conditions, the drug
permeated to a maximum depth of 5mm. Thus, the presence of
several bands arising from 5FU within the skin (Figure 1b) clearly
indicates that in situ hydrolysis of the prodrug has taken place.
Evaluation of the spatial variation of the relative prodrug
and drug concentrations requires an internal standard for
Raman intensity. A useful spectral feature for this purpose,
arising from endogenous skin proteins, is the ring-breathing
mode of phe at 1,004 cm1 (Figure 1b). This band diminishes
in intensity with depth in the skin, and serves to calibrate for
confocal scattering losses within the tissue (Figure S2). To
determine the relative concentrations of pro-5FU and 5FU in
skin, spectra of untreated skin are subtracted from spectra of
treated skin at equivalent depths (see Materials and Methods).
The difference spectra are shown in Figure 1c. The presence
of both pro-5FU and 5FU is evident in spectra acquired at
depths of 2, 7, and 12 mm beneath the skin surface. At a depth
of 17 mm, bands arising from the drug are no longer visible,
whereas the prodrug feature at 866 cm1 is close to the noise
level and is not considered significant. It is noted that the
band parameters (positions and widths) of pro-5FU and 5FU
in skin remain essentially unchanged from those in aqueous
solution (Figure 1a). As Raman band parameters are often
sensitive to environment, for example, solvent or intermole-
cular interactions, the similarity between the spectral features
of the drug and prodrug in skin and in aqueous solution
suggest that each molecule is located in an aqueous
environment in skin. Consistent with this suggestion is the
correlation between increased prodrug solubility in water and
increased 5FU delivery through hairless mouse skin reported
for this particular 5FU prodrug (Beall et al., 1994).
An issue arises as to the depths and regions of the skin into
which the prodrug or drug may permeate. More specifically,
it is of interest to ascertain whether permeation is limited to
the SC or whether the exogenous substances penetrate to the
viable epidermis or dermis. Univariate analysis of spectral
features or multivariate statistical algorithms such as factor
analysis can be used to delineate native skin regions, that is,
the methods are capable of differentiating the SC from the
viable epidermis (Xiao et al., 2004; Mendelsohn et al., 2006;
Zhang et al., 2007). Factor analysis was applied to a set of
confocal Raman spectra acquired from an untreated skin
sample over the 800–1,015 cm1 spectral region. Factor
scores are shown as image planes (Figure 2a–c) for loadings
that clearly differentiate the SC, viable epidermis, and dermis,
respectively. The pigskin sample used for this analysis was
taken from a biopsy similar to those used for pro-5FU
permeation experiments. From the factor score images, the
SC appears to beB10–20 mm thick. Thus, for the data shown
in Figure 1c, in which treated pigskin was incubated at 221C,
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Figure 1. Raman spectra (450–1015 cm1 region) probing pro-5FU (in IPM
suspension) delivery of 5FU in pigskin. (a) Raman spectra of neat IPM (dashed
line) and prodrug and drug solutions (solid lines, as noted). The molecular
structures of pro-5FU and 5FU are shown in the inset. (b) Confocal Raman
spectra of untreated (dashed lines) and pro-5FU-treated (solid lines) pigskin at
different depths (2, 7, 12, and 17 mm) under the skin surface from top to
bottom, respectively. Raman bands specific to prodrug (P) and drug (D), along
with the phe ring-breathing mode are marked. (c) Confocal Raman spectra of
pro-5FU-treated skin after subtraction of untreated skin spectra at equivalent
depths. Spectra are stacked top to bottom as in (b). Raman bands used to
quantify relative concentrations of prodrug (866 cm1) and drug (637 cm1)
are annotated.
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we conclude that the majority of prodrug and drug reside in
the SC and that permeation into the viable epidermis is not
detected.
To evaluate the temperature dependence, permeation
depths, and spatial distribution of the prodrug-to-drug
conversion, confocal Raman images were acquired at both
22 and 341C using a 5 mm step size. The higher temperature
corresponds to the average surface temperature of human
skin (Kraning, 1991). Image planes of the spatial distribution
of the relative concentrations of pro-5FU and 5FU are
presented in Figure 3 as band area ratios of the 866 and
637 cm1 bands for pro-5FU and 5FU, respectively, each
normalized to the phe band near 1,004 cm1, to correct for
confocal losses as discussed above. The observed permeation
differences between the two temperatures are striking.
Consistent with Figure 1c, permeation of both species at
221C is limited to the SC, whereas both are distributed
throughout the SC and viable epidermis at 341C. The
distribution of pro-5FU at the higher temperature in
Figure 3c shows a gradual decrease in concentration with
depth for the top B40 mm. In the lower half of the image
(viable epidermis), a few low concentration pockets (marked
with asterisks) are evident which correspond to higher
concentrations of drug (Figure 3d). It thus seems likely that
hydrolysis is taking place in both the SC and in the viable
epidermis.
Nonspecific hydrolytic esterase and lipase activity have
been observed in the intercellular spaces of the SC (Menon
et al., 1986; Beisson et al., 2001) and throughout the viable
epidermis (Sugibayashi et al., 1999; Redoules et al., 2005).
Although a detailed comparison of the hydrolytic potential
between the two skin regions has not been reported (to
our knowledge), it seems reasonable to assume that
conversion to 5FU would be more rapid in the viable
epidermis owing to differences in water content and the
presence of viable cells. The image of the drug-to-prodrug
mole ratio (Figure 3e) supports this assumption. The highest
relative amounts of drug with respect to prodrug are observed
in the viable epidermis at depths between 40 and 70 mm
from the skin surface (offset scale). Earlier reports of 5FU
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Figure 2. Factor analysis score image planes delineate skin regions. Factor
analysis was conducted on baseline corrected confocal Raman image planes
(8001,015 cm1 region) of untreated pigskin. The scores, red (highest) to
blue (lowest), depict the fit of three different loadings (factors) to the original
image plane and clearly differentiate the (a) SC, (b) viable epidermis, and
(c) dermis.
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Figure 3. Confocal Raman image planes depict the temperature dependent
permeation and hydrolysis of pro-5FU in pigskin. Pro-5FU treated pigskin
incubated at (a) and (b) 221C, and at (c) and (d) 341C. The spatial distribution
of pro-5FU concentration relative to phe present in endogenous skin proteins
is measured by the band area ratio 866/1004 cm1, in (a) and (c), and
similarly for relative 5FU concentration via the band area ratio, 637/1004 cm1,
in (b) and (d). The scale bars (right) apply to both respective image planes
(left). (e) Spatial distribution of the drug/prodrug mole ratio in pro-5FU treated
pigskin with scale bar shown to right. Several regions in the viable epidermis
have a relatively high concentration of drug (red) corresponding to low
prodrug concentrations relative to phe as marked by the asterisks in (c).
www.jidonline.org 1207
G Zhang et al.
Raman Imaging of Pro-5FU Hydrolysis in Skin
delivery in mouse skin using the current prodrug suggested
that the large amount of the promoiety delivered into the
skin might saturate the enzymes (Beall et al., 1994). In
addition, the influence and extent of enzyme leaching could
not be determined in earlier experiments where delivery was
examined using a diffusion cell in which the skin is in contact
with an aqueous receptor phase. Results from the current
experiments where enzyme leaching is not expected suggest
that while SC enzymes may be saturated, those in the viable
epidermis do not appear to be at this level of prodrug dosing
(see prodrug distribution in Figure 3c).
The increase in permeation at the higher temperature may
be caused by the direct effect of temperature on diffusion
along with a temperature-induced change in the SC barrier.
Since the lipid barrier in the standard model of the SC
(corneocytes embedded in a continuous lipid-enriched
matrix) is thought to be primarily responsible for barrier
function, we speculate that temperature-dependent changes
in the lipid are partially responsible for the increased
permeation. A temperature-induced solid–solid phase transi-
tion (orthorhombic to hexagonal acyl chain packing) in the
lipids of isolated human SC has been reported between 20
and 401C using transmission infrared (Mendelsohn et al.,
2006) and similarly for (cryo-) electron diffraction studies
(Pilgram et al., 1999). This transition occurs over a slightly
lower temperature range in isolated porcine SC (Figure S3),
most likely due to slight differences in porcine SC lipid
composition. The loosening in acyl chain packing may be
partially responsible for the increase in the observed prodrug
permeability. Unfortunately, the infrared parameters that
monitor this transition in isolated SC do not display the same
patterns of spectroscopic activity in the Raman measurement.
Therefore, this lipid transition cannot be detected in intact
skin using confocal Raman. The association of the permeants
with corneocyte envelopes or within corneocytes must also
be considered. The ability to obtain high quality infrared and
Raman spectra from isolated corneocytes has been demon-
strated (Zhang et al., 2006, 2007) and work in this area is
ongoing. It is possible that access to the cells increases with
the change in lipid packing.
One unanticipated result with important pharmacological
and therapeutic ramifications is the observation of solid drug
beneath the skin surface. The physical state (solution versus
solid) of permeated 5FU is easily identified in the Raman
spectra shown in Figure 4. Marker bands specific for solid
drug at 768 and 996 cm1 differ from those observed for 5FU
in aqueous solution and can be used to clearly differentiate
the state of 5FU in skin. The confocal Raman spectra of three
separate skin samples shown in Figure 4 were each obtained
from a depth of B35 mm underneath the surface, within the
viable epidermis. At this position within skin, the relative
concentration of 5FU as measured by the band area ratio of
637/1,004 cm1 for the spectrum noted as skinþ solid 5FU
(0.6) is well above the comparable maximum value shown in
Figure 3d (0.1). In spectra where the bands specific for solid
5FU (768 and 996 cm1) are present, the area of the phe band
(1,004 cm1) is obtained by doubling the integrated area of
the high frequency half of the band. Thus, increased delivery
of the prodrug and its conversion to its parent drug (5FU)
resulted in a supersaturated solution of 5FU from which some
solid 5FU precipitated.
The current confocal Raman investigation demonstrates
the feasibility of monitoring in situ the spatial distribution of
both prodrug and drug permeation in skin. The inherent
sensitivity of the spectra permits the discrimination of closely
related chemical species and physical states without the
introduction of potentially perturbing probes or elaborate
sample preparation. In addition, image planes of spectral
parameters depict permeation gradients with respect to skin
microanatomy (to depths of B70 mm). The techniques
employed herein are likely to be applicable to various
prodrug/drug topical skin treatments. Several combinations
are currently being investigated, as is the influence of these
agents on the conformation and distribution of endogenous
skin constituents.
MATERIALS AND METHODS
Materials
5FU and IPM were purchased from Sigma-Aldrich Chemical Co.
(St Louis, MO). Pro-5FU was synthesized as described in Beall et al.
(1994). Skin biopsies from Yucatan white, hairless pigs were
purchased from Sinclair Research Center Inc. (Columbia, MO).
Sample preparation
The Rutgers University Internal Review Board has approved all
protocols used herein. Aqueous solutions of pro-5FU (36 mM) and
5FU (22 mM) were prepared by warming to 601C for 5 minutes. To
keep the material dissolved, Raman spectra were acquired from
solutions in glass capillary tubes warmed on a heated stage. Separate
suspensions of pro-5FU and 5-FU in IPM were prepared by stirring
mixtures for 48 hours at room temperature. The concentration of
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Figure 4. Evidence for the presence of solid 5FU within pigskin epidermis
after treatment with pro-5FU. Raman spectra (600–1,020 cm1 region) of
an aqueous solution of 5FU, solid 5FU, and three separate pigskin samples
acquired at a depth B35 mm from the skin surface (top to bottom). Bands
marked at 996 and 768 cm1 are specific for solid 5FU. The endogenous skin
protein phe ring-breathing mode is also highlighted at 1,004 cm1.
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each suspension was 6 M yielding enough excess solid to maintain
saturation. Suspensions were topically applied to the SC of intact
skin at a surface coverage of 5ml/cm2. Samples were sealed to
prevent dehydration and held for 20 hours at either 22 or 341C after
which excess solid on the surface was rinsed off using fresh IPM. The
treated skin samples, SC side up, were gently pressed into a milled
brass cell, covered and sealed with a microscope coverslip for
confocal Raman measurements. Several (5–7) separate skin samples
were probed for prodrug/drug permeation at each temperature. In
addition, numerous confocal lines and planes of spectra acquired
from separate untreated skin samples were examined.
Confocal Raman microspectroscopy
Raman spectra were acquired with a Kaiser Optical Systems Raman
Microprobe (Ann Arbor, MI). The instrument has been described
previously in detail (Xiao et al., 2004, Zhang et al., 2007). Briefly,
excitation is achieved with a solid-state diode laser at 785 nm.
Approximately 12 mW of single mode power is focused with a
100 oil immersion objective to a volume of B2 mm3 within the
sample. The backscattered light illuminates a near-infrared CCD
(ANDOR Technology, Model DU 401-BR-DD) with spectral cover-
age over 100–3,450 cm1 at a spectral resolution of 4 cm1. Data are
encoded every 0.3 cm1 following linearization. Spectra are
acquired using a 60-second exposure time, four accumulations,
and cosmic ray correction. Confocal maps (axial lines and planes)
were obtained at room temperature perpendicular to the skin surface
using a step size of 5 mm. The time required to acquire an image
plane varies with size and spatial resolution. For the images shown
herein, acquisition time was 10 hours or less per sample. Previously
published protocols (Xiao et al., 2004, Zhang et al., 2007) were used
to evaluate axial characteristics of the current optical set-up. Briefly,
the use of the oil immersion lens provides better refractive index
matching with the skin sample than a dry objective, lessening depth
distortion (toB10%), and maximizing laser power. The actual
axial spatial resolution in the skin samples cannot be directly
ascertained.
Data analysis
Grams/32 AI software version 6.0 (ThermoGalactic, Salem, NH) was
used for processing individual Raman spectra. Raman spectra were
Fourier smoothed (80%) and a linear baseline was applied over the
800–1,014 cm1 region in both treated and untreated skin spectra to
better isolate the weak prodrug band at 866 cm1. The relatively
large degree of smoothing could be applied without distorting
spectral features. To evaluate the relative concentrations of pro-5FU
and 5FU at different depths in skin, spectra of untreated skin are
weighted (so as to normalize a pair of spectra to the phe band intensity)
and subtracted from spectra of treated skin at equivalent depths.
ISys software version 3.1 (Spectral Dimensions, Olney, MD) was
used to perform factor analysis, integrate band areas, and generate
Raman image planes. Factor analysis was performed as described
previously (Zhang et al., 2007) over 800–1,015 cm1 spectral region
using the iterative score segregation algorithm available in ISys
software.
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SUPPLEMENTARY MATERIAL
Figure S1. Raman spectra analyzing pro-5FU (in an IPM suspension) delivery
of 5FU in pigskin.
Figure S2. Confocal Raman scattering loss with depth in pigskin demonstrated
by an image plane of the integrated area of the phe ring-breathing mode
(995–1010 cm1).
Figure S3. Transmission infrared measurement evaluating lipid acyl chain
packing as a function of temperature in isolated SC.
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